Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest Profit Margin

Below are the top diagnostic substances stocks on the NASDAQ in terms of profit margin.

The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB) is 20.71%. Trinity Biotech's revenue for the same period is $81.70 million.

The trailing-twelve-month profit margin at Meridian Bioscience (NASDAQ: VIVO) is 19.23%. Meridian Bioscience's ROA for the same period is 19.85%.

The trailing-twelve-month profit margin at IDEXX Laboratories (NASDAQ: IDXX) is 13.50%. IDEXX Laboratories' ROE for the same period is 28.74%.

The trailing-twelve-month profit margin at Neogen (NASDAQ: NEOG) is 12.78%. Neogen's PEG ratio is 2.19.